nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—Barrett's esophagus—stomach cancer	0.616	1	CtDrD
Omeprazole—ABCC3—Fluorouracil—stomach cancer	0.0333	0.143	CbGbCtD
Omeprazole—CYP1B1—Docetaxel—stomach cancer	0.022	0.0941	CbGbCtD
Omeprazole—ABCB1—Mitomycin—stomach cancer	0.02	0.0858	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—stomach cancer	0.0189	0.0812	CbGbCtD
Omeprazole—ABCC3—Methotrexate—stomach cancer	0.0184	0.0787	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—stomach cancer	0.0164	0.0702	CbGbCtD
Omeprazole—ABCG2—Irinotecan—stomach cancer	0.0143	0.0611	CbGbCtD
Omeprazole—ABCG2—Fluorouracil—stomach cancer	0.0137	0.0586	CbGbCtD
Omeprazole—ATP4A—gastric juice—stomach cancer	0.0109	0.34	CbGeAlD
Omeprazole—ABCG2—Docetaxel—stomach cancer	0.0104	0.0448	CbGbCtD
Omeprazole—CYP2C9—Capecitabine—stomach cancer	0.00857	0.0367	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—stomach cancer	0.00778	0.0334	CbGbCtD
Omeprazole—ABCG2—Methotrexate—stomach cancer	0.00754	0.0323	CbGbCtD
Omeprazole—CYP2C8—Fluorouracil—stomach cancer	0.00729	0.0312	CbGbCtD
Omeprazole—CYP1A2—Fluorouracil—stomach cancer	0.00564	0.0242	CbGbCtD
Omeprazole—ABCB1—Irinotecan—stomach cancer	0.00514	0.022	CbGbCtD
Omeprazole—CYP2C9—Fluorouracil—stomach cancer	0.00508	0.0218	CbGbCtD
Omeprazole—ABCB1—Docetaxel—stomach cancer	0.00377	0.0161	CbGbCtD
Omeprazole—CYP3A4—Irinotecan—stomach cancer	0.00308	0.0132	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—stomach cancer	0.00281	0.012	CbGbCtD
Omeprazole—ABCB1—Methotrexate—stomach cancer	0.00272	0.0117	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—stomach cancer	0.00264	0.0113	CbGbCtD
Omeprazole—CYP3A4—Docetaxel—stomach cancer	0.00226	0.00967	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—stomach cancer	0.00168	0.00721	CbGbCtD
Omeprazole—ATP4B—digestive system—stomach cancer	0.00153	0.0477	CbGeAlD
Omeprazole—ATP4B—endocrine gland—stomach cancer	0.00126	0.0394	CbGeAlD
Omeprazole—ATP4B—liver—stomach cancer	0.00114	0.0355	CbGeAlD
Omeprazole—ATP4A—hematopoietic system—stomach cancer	0.000957	0.0298	CbGeAlD
Omeprazole—ATP4A—epithelium—stomach cancer	0.000875	0.0273	CbGeAlD
Omeprazole—ABCC3—gall bladder—stomach cancer	0.00086	0.0268	CbGeAlD
Omeprazole—ATP4A—digestive system—stomach cancer	0.000665	0.0208	CbGeAlD
Omeprazole—CYP11A1—hematopoietic system—stomach cancer	0.000627	0.0196	CbGeAlD
Omeprazole—ATP4A—endocrine gland—stomach cancer	0.00055	0.0172	CbGeAlD
Omeprazole—CYP2C18—digestive system—stomach cancer	0.000547	0.0171	CbGeAlD
Omeprazole—ATP4A—liver—stomach cancer	0.000496	0.0155	CbGeAlD
Omeprazole—ABCC3—hematopoietic system—stomach cancer	0.000487	0.0152	CbGeAlD
Omeprazole—CYP2C18—endocrine gland—stomach cancer	0.000452	0.0141	CbGeAlD
Omeprazole—CYP2C18—liver—stomach cancer	0.000407	0.0127	CbGeAlD
Omeprazole—CYP1B1—hematopoietic system—stomach cancer	0.000381	0.0119	CbGeAlD
Omeprazole—CYP11A1—endocrine gland—stomach cancer	0.00036	0.0112	CbGeAlD
Omeprazole—ABCC3—digestive system—stomach cancer	0.000339	0.0106	CbGeAlD
Omeprazole—CYP1B1—smooth muscle tissue—stomach cancer	0.000336	0.0105	CbGeAlD
Omeprazole—CYP2C19—hematopoietic system—stomach cancer	0.000334	0.0104	CbGeAlD
Omeprazole—CYP2C8—hematopoietic system—stomach cancer	0.000292	0.0091	CbGeAlD
Omeprazole—ABCC3—endocrine gland—stomach cancer	0.00028	0.00873	CbGeAlD
Omeprazole—CYP1A2—hematopoietic system—stomach cancer	0.000273	0.00852	CbGeAlD
Omeprazole—CYP1A1—hematopoietic system—stomach cancer	0.000269	0.0084	CbGeAlD
Omeprazole—CYP1B1—lymphoid tissue—stomach cancer	0.000268	0.00837	CbGeAlD
Omeprazole—CYP1B1—digestive system—stomach cancer	0.000265	0.00826	CbGeAlD
Omeprazole—ABCB1—blood vessel—stomach cancer	0.000263	0.00819	CbGeAlD
Omeprazole—CYP2C9—hematopoietic system—stomach cancer	0.000259	0.00808	CbGeAlD
Omeprazole—ABCC3—liver—stomach cancer	0.000252	0.00787	CbGeAlD
Omeprazole—CYP11A1—lymph node—stomach cancer	0.000249	0.00777	CbGeAlD
Omeprazole—CYP1A1—epithelium—stomach cancer	0.000246	0.00768	CbGeAlD
Omeprazole—CYP2C19—digestive system—stomach cancer	0.000232	0.00725	CbGeAlD
Omeprazole—CYP1B1—endocrine gland—stomach cancer	0.000219	0.00683	CbGeAlD
Omeprazole—CYP3A4—hematopoietic system—stomach cancer	0.000198	0.00616	CbGeAlD
Omeprazole—CYP1B1—liver—stomach cancer	0.000197	0.00616	CbGeAlD
Omeprazole—CYP2D6—hematopoietic system—stomach cancer	0.000194	0.00607	CbGeAlD
Omeprazole—ABCC3—lymph node—stomach cancer	0.000193	0.00603	CbGeAlD
Omeprazole—CYP2C19—endocrine gland—stomach cancer	0.000192	0.00599	CbGeAlD
Omeprazole—CYP1A2—digestive system—stomach cancer	0.00019	0.00592	CbGeAlD
Omeprazole—CYP1A1—digestive system—stomach cancer	0.000187	0.00584	CbGeAlD
Omeprazole—ABCG2—bone marrow—stomach cancer	0.000182	0.00567	CbGeAlD
Omeprazole—CYP2C9—digestive system—stomach cancer	0.00018	0.00562	CbGeAlD
Omeprazole—CYP2C19—liver—stomach cancer	0.000173	0.0054	CbGeAlD
Omeprazole—CYP2C8—endocrine gland—stomach cancer	0.000168	0.00523	CbGeAlD
Omeprazole—CYP1A2—endocrine gland—stomach cancer	0.000157	0.00489	CbGeAlD
Omeprazole—CYP1A1—endocrine gland—stomach cancer	0.000155	0.00483	CbGeAlD
Omeprazole—CYP1B1—lymph node—stomach cancer	0.000151	0.00472	CbGeAlD
Omeprazole—CYP2C8—liver—stomach cancer	0.000151	0.00471	CbGeAlD
Omeprazole—CYP2C9—endocrine gland—stomach cancer	0.000149	0.00465	CbGeAlD
Omeprazole—ABCG2—liver—stomach cancer	0.000147	0.00458	CbGeAlD
Omeprazole—CYP1A2—liver—stomach cancer	0.000141	0.00441	CbGeAlD
Omeprazole—ABCB1—hematopoietic system—stomach cancer	0.00014	0.00436	CbGeAlD
Omeprazole—CYP1A1—liver—stomach cancer	0.00014	0.00435	CbGeAlD
Omeprazole—CYP3A4—digestive system—stomach cancer	0.000137	0.00429	CbGeAlD
Omeprazole—CYP2D6—digestive system—stomach cancer	0.000135	0.00422	CbGeAlD
Omeprazole—CYP2C9—liver—stomach cancer	0.000134	0.00419	CbGeAlD
Omeprazole—ABCB1—epithelium—stomach cancer	0.000128	0.00399	CbGeAlD
Omeprazole—ABCB1—pancreas—stomach cancer	0.000114	0.00355	CbGeAlD
Omeprazole—CYP3A4—endocrine gland—stomach cancer	0.000114	0.00354	CbGeAlD
Omeprazole—ABCG2—lymph node—stomach cancer	0.000113	0.00351	CbGeAlD
Omeprazole—CYP2D6—endocrine gland—stomach cancer	0.000112	0.00349	CbGeAlD
Omeprazole—CYP1A1—lymph node—stomach cancer	0.000107	0.00334	CbGeAlD
Omeprazole—CYP3A4—liver—stomach cancer	0.000102	0.00319	CbGeAlD
Omeprazole—CYP2D6—liver—stomach cancer	0.000101	0.00314	CbGeAlD
Omeprazole—ABCB1—lymphoid tissue—stomach cancer	9.85e-05	0.00307	CbGeAlD
Omeprazole—ABCB1—digestive system—stomach cancer	9.73e-05	0.00303	CbGeAlD
Omeprazole—ABCB1—bone marrow—stomach cancer	8.97e-05	0.0028	CbGeAlD
Omeprazole—ABCB1—endocrine gland—stomach cancer	8.04e-05	0.00251	CbGeAlD
Omeprazole—ABCB1—liver—stomach cancer	7.25e-05	0.00226	CbGeAlD
Omeprazole—ABCB1—lymph node—stomach cancer	5.56e-05	0.00173	CbGeAlD
Omeprazole—Alopecia—Methotrexate—stomach cancer	3.55e-05	0.000425	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—stomach cancer	3.54e-05	0.000424	CcSEcCtD
Omeprazole—Dyspnoea—Docetaxel—stomach cancer	3.53e-05	0.000423	CcSEcCtD
Omeprazole—Somnolence—Docetaxel—stomach cancer	3.52e-05	0.000422	CcSEcCtD
Omeprazole—Mental disorder—Methotrexate—stomach cancer	3.52e-05	0.000421	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—stomach cancer	3.51e-05	0.000421	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—stomach cancer	3.5e-05	0.00042	CcSEcCtD
Omeprazole—Malnutrition—Methotrexate—stomach cancer	3.49e-05	0.000419	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Capecitabine—stomach cancer	3.49e-05	0.000418	CcSEcCtD
Omeprazole—Flushing—Epirubicin—stomach cancer	3.49e-05	0.000418	CcSEcCtD
Omeprazole—Vomiting—Fluorouracil—stomach cancer	3.48e-05	0.000418	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—stomach cancer	3.48e-05	0.000418	CcSEcCtD
Omeprazole—Dyspepsia—Docetaxel—stomach cancer	3.48e-05	0.000417	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—stomach cancer	3.47e-05	0.000417	CcSEcCtD
Omeprazole—Insomnia—Capecitabine—stomach cancer	3.46e-05	0.000415	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—stomach cancer	3.46e-05	0.000414	CcSEcCtD
Omeprazole—Rash—Fluorouracil—stomach cancer	3.46e-05	0.000414	CcSEcCtD
Omeprazole—Dermatitis—Fluorouracil—stomach cancer	3.45e-05	0.000414	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—stomach cancer	3.45e-05	0.000413	CcSEcCtD
Omeprazole—Paraesthesia—Capecitabine—stomach cancer	3.44e-05	0.000412	CcSEcCtD
Omeprazole—Decreased appetite—Docetaxel—stomach cancer	3.44e-05	0.000412	CcSEcCtD
Omeprazole—Headache—Fluorouracil—stomach cancer	3.43e-05	0.000412	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—stomach cancer	3.43e-05	0.000411	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—stomach cancer	3.42e-05	0.00041	CcSEcCtD
Omeprazole—Dysgeusia—Methotrexate—stomach cancer	3.42e-05	0.00041	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Docetaxel—stomach cancer	3.41e-05	0.000409	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—stomach cancer	3.41e-05	0.000409	CcSEcCtD
Omeprazole—Dyspnoea—Capecitabine—stomach cancer	3.41e-05	0.000409	CcSEcCtD
Omeprazole—Fatigue—Docetaxel—stomach cancer	3.41e-05	0.000409	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—stomach cancer	3.41e-05	0.000408	CcSEcCtD
Omeprazole—Nausea—Irinotecan—stomach cancer	3.4e-05	0.000407	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—stomach cancer	3.39e-05	0.000407	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—stomach cancer	3.38e-05	0.000406	CcSEcCtD
Omeprazole—Pain—Docetaxel—stomach cancer	3.38e-05	0.000406	CcSEcCtD
Omeprazole—Constipation—Docetaxel—stomach cancer	3.38e-05	0.000406	CcSEcCtD
Omeprazole—Back pain—Methotrexate—stomach cancer	3.38e-05	0.000405	CcSEcCtD
Omeprazole—Dyspepsia—Capecitabine—stomach cancer	3.37e-05	0.000404	CcSEcCtD
Omeprazole—Chills—Epirubicin—stomach cancer	3.37e-05	0.000404	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—stomach cancer	3.35e-05	0.000401	CcSEcCtD
Omeprazole—Decreased appetite—Capecitabine—stomach cancer	3.33e-05	0.000399	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—stomach cancer	3.32e-05	0.000398	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Capecitabine—stomach cancer	3.31e-05	0.000396	CcSEcCtD
Omeprazole—Fatigue—Capecitabine—stomach cancer	3.3e-05	0.000396	CcSEcCtD
Omeprazole—Vision blurred—Methotrexate—stomach cancer	3.29e-05	0.000395	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—stomach cancer	3.29e-05	0.000394	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—stomach cancer	3.29e-05	0.000394	CcSEcCtD
Omeprazole—Constipation—Capecitabine—stomach cancer	3.27e-05	0.000393	CcSEcCtD
Omeprazole—Pain—Capecitabine—stomach cancer	3.27e-05	0.000393	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—stomach cancer	3.27e-05	0.000392	CcSEcCtD
Omeprazole—Feeling abnormal—Docetaxel—stomach cancer	3.26e-05	0.000391	CcSEcCtD
Omeprazole—Nausea—Fluorouracil—stomach cancer	3.26e-05	0.00039	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—stomach cancer	3.25e-05	0.000389	CcSEcCtD
Omeprazole—Ill-defined disorder—Methotrexate—stomach cancer	3.24e-05	0.000389	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—stomach cancer	3.24e-05	0.000388	CcSEcCtD
Omeprazole—Gastrointestinal pain—Docetaxel—stomach cancer	3.23e-05	0.000388	CcSEcCtD
Omeprazole—Anaemia—Methotrexate—stomach cancer	3.23e-05	0.000387	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—stomach cancer	3.22e-05	0.000387	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—stomach cancer	3.22e-05	0.000386	CcSEcCtD
Omeprazole—Tension—Epirubicin—stomach cancer	3.21e-05	0.000385	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—stomach cancer	3.2e-05	0.000384	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—stomach cancer	3.17e-05	0.000381	CcSEcCtD
Omeprazole—Back pain—Epirubicin—stomach cancer	3.16e-05	0.000379	CcSEcCtD
Omeprazole—Feeling abnormal—Capecitabine—stomach cancer	3.16e-05	0.000378	CcSEcCtD
Omeprazole—Malaise—Methotrexate—stomach cancer	3.15e-05	0.000378	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—stomach cancer	3.14e-05	0.000377	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—stomach cancer	3.14e-05	0.000376	CcSEcCtD
Omeprazole—Vertigo—Methotrexate—stomach cancer	3.14e-05	0.000376	CcSEcCtD
Omeprazole—Gastrointestinal pain—Capecitabine—stomach cancer	3.13e-05	0.000375	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—stomach cancer	3.13e-05	0.000375	CcSEcCtD
Omeprazole—Abdominal pain—Docetaxel—stomach cancer	3.13e-05	0.000375	CcSEcCtD
Omeprazole—Body temperature increased—Docetaxel—stomach cancer	3.13e-05	0.000375	CcSEcCtD
Omeprazole—Leukopenia—Methotrexate—stomach cancer	3.13e-05	0.000375	CcSEcCtD
Omeprazole—Chills—Doxorubicin—stomach cancer	3.12e-05	0.000374	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—stomach cancer	3.08e-05	0.000369	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—stomach cancer	3.07e-05	0.000368	CcSEcCtD
Omeprazole—Cough—Methotrexate—stomach cancer	3.05e-05	0.000365	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—stomach cancer	3.04e-05	0.000365	CcSEcCtD
Omeprazole—Urticaria—Capecitabine—stomach cancer	3.04e-05	0.000365	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—stomach cancer	3.03e-05	0.000364	CcSEcCtD
Omeprazole—Abdominal pain—Capecitabine—stomach cancer	3.03e-05	0.000363	CcSEcCtD
Omeprazole—Body temperature increased—Capecitabine—stomach cancer	3.03e-05	0.000363	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—stomach cancer	3.02e-05	0.000363	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—stomach cancer	3.02e-05	0.000362	CcSEcCtD
Omeprazole—Agitation—Epirubicin—stomach cancer	3e-05	0.00036	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—stomach cancer	2.98e-05	0.000357	CcSEcCtD
Omeprazole—Arthralgia—Methotrexate—stomach cancer	2.97e-05	0.000357	CcSEcCtD
Omeprazole—Chest pain—Methotrexate—stomach cancer	2.97e-05	0.000357	CcSEcCtD
Omeprazole—Myalgia—Methotrexate—stomach cancer	2.97e-05	0.000357	CcSEcCtD
Omeprazole—Tension—Doxorubicin—stomach cancer	2.97e-05	0.000356	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—stomach cancer	2.96e-05	0.000355	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	2.95e-05	0.000354	CcSEcCtD
Omeprazole—Malaise—Epirubicin—stomach cancer	2.95e-05	0.000353	CcSEcCtD
Omeprazole—Discomfort—Methotrexate—stomach cancer	2.94e-05	0.000352	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—stomach cancer	2.94e-05	0.000352	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—stomach cancer	2.94e-05	0.000352	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—stomach cancer	2.93e-05	0.000351	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—stomach cancer	2.93e-05	0.000351	CcSEcCtD
Omeprazole—Hypersensitivity—Docetaxel—stomach cancer	2.91e-05	0.000349	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—stomach cancer	2.91e-05	0.000349	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—stomach cancer	2.89e-05	0.000346	CcSEcCtD
Omeprazole—Confusional state—Methotrexate—stomach cancer	2.87e-05	0.000345	CcSEcCtD
Omeprazole—Cough—Epirubicin—stomach cancer	2.85e-05	0.000342	CcSEcCtD
Omeprazole—Anaphylactic shock—Methotrexate—stomach cancer	2.85e-05	0.000342	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—stomach cancer	2.85e-05	0.000342	CcSEcCtD
Omeprazole—Asthenia—Docetaxel—stomach cancer	2.84e-05	0.00034	CcSEcCtD
Omeprazole—Infection—Methotrexate—stomach cancer	2.83e-05	0.00034	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—stomach cancer	2.82e-05	0.000338	CcSEcCtD
Omeprazole—Hypersensitivity—Capecitabine—stomach cancer	2.82e-05	0.000338	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—stomach cancer	2.81e-05	0.000336	CcSEcCtD
Omeprazole—Pruritus—Docetaxel—stomach cancer	2.8e-05	0.000335	CcSEcCtD
Omeprazole—Nervous system disorder—Methotrexate—stomach cancer	2.8e-05	0.000335	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—stomach cancer	2.8e-05	0.000335	CcSEcCtD
Omeprazole—Thrombocytopenia—Methotrexate—stomach cancer	2.79e-05	0.000335	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—stomach cancer	2.78e-05	0.000334	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—stomach cancer	2.78e-05	0.000334	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—stomach cancer	2.78e-05	0.000334	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—stomach cancer	2.78e-05	0.000333	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—stomach cancer	2.77e-05	0.000332	CcSEcCtD
Omeprazole—Skin disorder—Methotrexate—stomach cancer	2.77e-05	0.000332	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	2.76e-05	0.000331	CcSEcCtD
Omeprazole—Hyperhidrosis—Methotrexate—stomach cancer	2.76e-05	0.00033	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—stomach cancer	2.75e-05	0.00033	CcSEcCtD
Omeprazole—Asthenia—Capecitabine—stomach cancer	2.75e-05	0.000329	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—stomach cancer	2.73e-05	0.000327	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—stomach cancer	2.72e-05	0.000326	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—stomach cancer	2.72e-05	0.000326	CcSEcCtD
Omeprazole—Anorexia—Methotrexate—stomach cancer	2.72e-05	0.000326	CcSEcCtD
Omeprazole—Pruritus—Capecitabine—stomach cancer	2.71e-05	0.000325	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—stomach cancer	2.71e-05	0.000325	CcSEcCtD
Omeprazole—Diarrhoea—Docetaxel—stomach cancer	2.71e-05	0.000324	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—stomach cancer	2.69e-05	0.000322	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—stomach cancer	2.67e-05	0.00032	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—stomach cancer	2.67e-05	0.00032	CcSEcCtD
Omeprazole—Infection—Epirubicin—stomach cancer	2.65e-05	0.000318	CcSEcCtD
Omeprazole—Cough—Doxorubicin—stomach cancer	2.64e-05	0.000316	CcSEcCtD
Omeprazole—Shock—Epirubicin—stomach cancer	2.62e-05	0.000315	CcSEcCtD
Omeprazole—Diarrhoea—Capecitabine—stomach cancer	2.62e-05	0.000314	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—stomach cancer	2.62e-05	0.000314	CcSEcCtD
Omeprazole—Dizziness—Docetaxel—stomach cancer	2.62e-05	0.000314	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—stomach cancer	2.61e-05	0.000313	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—stomach cancer	2.61e-05	0.000313	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—stomach cancer	2.6e-05	0.000312	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methotrexate—stomach cancer	2.6e-05	0.000311	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—stomach cancer	2.59e-05	0.000311	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—stomach cancer	2.58e-05	0.000309	CcSEcCtD
Omeprazole—Insomnia—Methotrexate—stomach cancer	2.58e-05	0.000309	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—stomach cancer	2.58e-05	0.000309	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—stomach cancer	2.58e-05	0.000309	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—stomach cancer	2.58e-05	0.000309	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—stomach cancer	2.57e-05	0.000308	CcSEcCtD
Omeprazole—Paraesthesia—Methotrexate—stomach cancer	2.56e-05	0.000307	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	2.56e-05	0.000307	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—stomach cancer	2.54e-05	0.000305	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—stomach cancer	2.54e-05	0.000305	CcSEcCtD
Omeprazole—Dyspnoea—Methotrexate—stomach cancer	2.54e-05	0.000305	CcSEcCtD
Omeprazole—Somnolence—Methotrexate—stomach cancer	2.53e-05	0.000304	CcSEcCtD
Omeprazole—Dizziness—Capecitabine—stomach cancer	2.53e-05	0.000304	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—stomach cancer	2.52e-05	0.000302	CcSEcCtD
Omeprazole—Vomiting—Docetaxel—stomach cancer	2.51e-05	0.000301	CcSEcCtD
Omeprazole—Dyspepsia—Methotrexate—stomach cancer	2.51e-05	0.000301	CcSEcCtD
Omeprazole—Rash—Docetaxel—stomach cancer	2.49e-05	0.000299	CcSEcCtD
Omeprazole—Dermatitis—Docetaxel—stomach cancer	2.49e-05	0.000299	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—stomach cancer	2.49e-05	0.000298	CcSEcCtD
Omeprazole—Decreased appetite—Methotrexate—stomach cancer	2.48e-05	0.000297	CcSEcCtD
Omeprazole—Headache—Docetaxel—stomach cancer	2.48e-05	0.000297	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—stomach cancer	2.47e-05	0.000296	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Methotrexate—stomach cancer	2.46e-05	0.000295	CcSEcCtD
Omeprazole—Fatigue—Methotrexate—stomach cancer	2.46e-05	0.000295	CcSEcCtD
Omeprazole—Infection—Doxorubicin—stomach cancer	2.45e-05	0.000294	CcSEcCtD
Omeprazole—Pain—Methotrexate—stomach cancer	2.44e-05	0.000292	CcSEcCtD
Omeprazole—Vomiting—Capecitabine—stomach cancer	2.43e-05	0.000292	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—stomach cancer	2.43e-05	0.000291	CcSEcCtD
Omeprazole—Shock—Doxorubicin—stomach cancer	2.43e-05	0.000291	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—stomach cancer	2.42e-05	0.00029	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—stomach cancer	2.42e-05	0.00029	CcSEcCtD
Omeprazole—Rash—Capecitabine—stomach cancer	2.41e-05	0.000289	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—stomach cancer	2.41e-05	0.000289	CcSEcCtD
Omeprazole—Dermatitis—Capecitabine—stomach cancer	2.41e-05	0.000289	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—stomach cancer	2.41e-05	0.000289	CcSEcCtD
Omeprazole—Headache—Capecitabine—stomach cancer	2.4e-05	0.000288	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—stomach cancer	2.4e-05	0.000287	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—stomach cancer	2.4e-05	0.000287	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—stomach cancer	2.39e-05	0.000286	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—stomach cancer	2.38e-05	0.000285	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—stomach cancer	2.37e-05	0.000284	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—stomach cancer	2.35e-05	0.000282	CcSEcCtD
Omeprazole—Nausea—Docetaxel—stomach cancer	2.35e-05	0.000282	CcSEcCtD
Omeprazole—Feeling abnormal—Methotrexate—stomach cancer	2.35e-05	0.000282	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—stomach cancer	2.35e-05	0.000282	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methotrexate—stomach cancer	2.33e-05	0.000279	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—stomach cancer	2.32e-05	0.000278	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—stomach cancer	2.3e-05	0.000276	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—stomach cancer	2.3e-05	0.000276	CcSEcCtD
Omeprazole—Pain—Epirubicin—stomach cancer	2.28e-05	0.000274	CcSEcCtD
Omeprazole—Constipation—Epirubicin—stomach cancer	2.28e-05	0.000274	CcSEcCtD
Omeprazole—Nausea—Capecitabine—stomach cancer	2.27e-05	0.000273	CcSEcCtD
Omeprazole—Urticaria—Methotrexate—stomach cancer	2.26e-05	0.000272	CcSEcCtD
Omeprazole—Abdominal pain—Methotrexate—stomach cancer	2.25e-05	0.00027	CcSEcCtD
Omeprazole—Body temperature increased—Methotrexate—stomach cancer	2.25e-05	0.00027	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—stomach cancer	2.25e-05	0.00027	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—stomach cancer	2.23e-05	0.000268	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—stomach cancer	2.22e-05	0.000266	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—stomach cancer	2.2e-05	0.000264	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—stomach cancer	2.2e-05	0.000264	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—stomach cancer	2.19e-05	0.000263	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—stomach cancer	2.18e-05	0.000262	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—stomach cancer	2.17e-05	0.000261	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—stomach cancer	2.15e-05	0.000257	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—stomach cancer	2.13e-05	0.000255	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—stomach cancer	2.13e-05	0.000255	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—stomach cancer	2.12e-05	0.000254	CcSEcCtD
Omeprazole—Pain—Doxorubicin—stomach cancer	2.11e-05	0.000253	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—stomach cancer	2.11e-05	0.000253	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—stomach cancer	2.11e-05	0.000253	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—stomach cancer	2.11e-05	0.000253	CcSEcCtD
Omeprazole—Hypersensitivity—Methotrexate—stomach cancer	2.1e-05	0.000252	CcSEcCtD
Omeprazole—Asthenia—Methotrexate—stomach cancer	2.05e-05	0.000245	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—stomach cancer	2.03e-05	0.000244	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—stomach cancer	2.02e-05	0.000242	CcSEcCtD
Omeprazole—Pruritus—Methotrexate—stomach cancer	2.02e-05	0.000242	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—stomach cancer	1.97e-05	0.000236	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—stomach cancer	1.96e-05	0.000235	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—stomach cancer	1.95e-05	0.000234	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—stomach cancer	1.95e-05	0.000234	CcSEcCtD
Omeprazole—Diarrhoea—Methotrexate—stomach cancer	1.95e-05	0.000234	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—stomach cancer	1.91e-05	0.000229	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—stomach cancer	1.89e-05	0.000226	CcSEcCtD
Omeprazole—Dizziness—Methotrexate—stomach cancer	1.89e-05	0.000226	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—stomach cancer	1.83e-05	0.000219	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—stomach cancer	1.82e-05	0.000218	CcSEcCtD
Omeprazole—Vomiting—Methotrexate—stomach cancer	1.81e-05	0.000217	CcSEcCtD
Omeprazole—Rash—Methotrexate—stomach cancer	1.8e-05	0.000215	CcSEcCtD
Omeprazole—Dermatitis—Methotrexate—stomach cancer	1.8e-05	0.000215	CcSEcCtD
Omeprazole—Headache—Methotrexate—stomach cancer	1.79e-05	0.000214	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—stomach cancer	1.77e-05	0.000212	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—stomach cancer	1.76e-05	0.000212	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—stomach cancer	1.75e-05	0.000209	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—stomach cancer	1.7e-05	0.000203	CcSEcCtD
Omeprazole—Nausea—Methotrexate—stomach cancer	1.69e-05	0.000203	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—stomach cancer	1.69e-05	0.000202	CcSEcCtD
Omeprazole—Rash—Epirubicin—stomach cancer	1.68e-05	0.000202	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—stomach cancer	1.68e-05	0.000201	CcSEcCtD
Omeprazole—Headache—Epirubicin—stomach cancer	1.67e-05	0.0002	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—stomach cancer	1.63e-05	0.000196	CcSEcCtD
Omeprazole—Nausea—Epirubicin—stomach cancer	1.58e-05	0.00019	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—stomach cancer	1.57e-05	0.000188	CcSEcCtD
Omeprazole—Rash—Doxorubicin—stomach cancer	1.56e-05	0.000187	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—stomach cancer	1.56e-05	0.000186	CcSEcCtD
Omeprazole—Headache—Doxorubicin—stomach cancer	1.55e-05	0.000185	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—stomach cancer	1.47e-05	0.000176	CcSEcCtD
Omeprazole—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.88e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CA1—stomach cancer	3.88e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CKB—stomach cancer	3.88e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—RORA—stomach cancer	3.88e-06	0.000109	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PPARG—stomach cancer	3.86e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ERCC2—stomach cancer	3.83e-06	0.000108	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PDHA1—stomach cancer	3.81e-06	0.000107	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ECHS1—stomach cancer	3.81e-06	0.000107	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKR1C3—stomach cancer	3.79e-06	0.000107	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.76e-06	0.000106	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—TYMS—stomach cancer	3.75e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.75e-06	0.000106	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.74e-06	0.000105	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSTM1—stomach cancer	3.71e-06	0.000105	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALOX5—stomach cancer	3.71e-06	0.000105	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.7e-06	0.000104	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ENO1—stomach cancer	3.69e-06	0.000104	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALDOB—stomach cancer	3.67e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PLIN2—stomach cancer	3.65e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—DPYD—stomach cancer	3.65e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALDOB—stomach cancer	3.64e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.63e-06	0.000102	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALOX5—stomach cancer	3.62e-06	0.000102	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.62e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTT1—stomach cancer	3.61e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—stomach cancer	3.6e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—MTHFR—stomach cancer	3.6e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMP—stomach cancer	3.58e-06	0.000101	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—FADS1—stomach cancer	3.58e-06	0.000101	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP2A6—stomach cancer	3.57e-06	0.000101	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ALB—stomach cancer	3.56e-06	0.0001	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—DPYD—stomach cancer	3.56e-06	0.0001	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CA2—stomach cancer	3.55e-06	0.0001	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ERCC2—stomach cancer	3.49e-06	9.83e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.48e-06	9.82e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKR1C3—stomach cancer	3.47e-06	9.79e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ALB—stomach cancer	3.47e-06	9.77e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PGAM1—stomach cancer	3.46e-06	9.75e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NT5E—stomach cancer	3.46e-06	9.75e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.43e-06	9.67e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.42e-06	9.64e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALOX5—stomach cancer	3.41e-06	9.61e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—NOS3—stomach cancer	3.41e-06	9.61e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ENO1—stomach cancer	3.39e-06	9.55e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALOX5—stomach cancer	3.38e-06	9.53e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SREBF2—stomach cancer	3.36e-06	9.46e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—DPYD—stomach cancer	3.35e-06	9.46e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.33e-06	9.39e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—DPYD—stomach cancer	3.33e-06	9.38e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CAV1—stomach cancer	3.32e-06	9.37e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—RORA—stomach cancer	3.32e-06	9.35e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—NOS3—stomach cancer	3.32e-06	9.35e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—APOA1—stomach cancer	3.32e-06	9.35e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.31e-06	9.32e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.3e-06	9.3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PLCE1—stomach cancer	3.3e-06	9.3e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—MTHFR—stomach cancer	3.28e-06	9.24e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CD44—stomach cancer	3.28e-06	9.23e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTT1—stomach cancer	3.23e-06	9.09e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP2A6—stomach cancer	3.19e-06	8.99e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.18e-06	8.96e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.17e-06	8.95e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—UMPS—stomach cancer	3.16e-06	8.92e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTT1—stomach cancer	3.15e-06	8.87e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—stomach cancer	3.12e-06	8.79e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP2A6—stomach cancer	3.11e-06	8.77e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALDOB—stomach cancer	3.11e-06	8.76e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKR1C3—stomach cancer	3.1e-06	8.74e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—stomach cancer	3.03e-06	8.55e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKR1C3—stomach cancer	3.03e-06	8.53e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CAV1—stomach cancer	3.02e-06	8.52e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ENO1—stomach cancer	3.02e-06	8.52e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—APOA1—stomach cancer	3.02e-06	8.5e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.01e-06	8.5e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CD44—stomach cancer	3e-06	8.47e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.97e-06	8.38e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTT1—stomach cancer	2.97e-06	8.36e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ENO1—stomach cancer	2.95e-06	8.32e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PDHA1—stomach cancer	2.94e-06	8.29e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ECHS1—stomach cancer	2.94e-06	8.29e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTT1—stomach cancer	2.94e-06	8.29e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP2A6—stomach cancer	2.93e-06	8.27e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.93e-06	8.26e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.92e-06	8.24e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—stomach cancer	2.92e-06	8.24e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.91e-06	8.21e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP2A6—stomach cancer	2.91e-06	8.19e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALOX5—stomach cancer	2.89e-06	8.14e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKR1C3—stomach cancer	2.85e-06	8.04e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—DPYD—stomach cancer	2.84e-06	8.01e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKR1C3—stomach cancer	2.83e-06	7.97e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPP2R1A—stomach cancer	2.79e-06	7.85e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ENO1—stomach cancer	2.78e-06	7.84e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—FADS1—stomach cancer	2.77e-06	7.8e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMP—stomach cancer	2.77e-06	7.8e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.76e-06	7.78e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ENO1—stomach cancer	2.76e-06	7.77e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTP1—stomach cancer	2.73e-06	7.7e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.71e-06	7.64e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—HMOX1—stomach cancer	2.69e-06	7.6e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CD44—stomach cancer	2.68e-06	7.56e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—stomach cancer	2.66e-06	7.49e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ALB—stomach cancer	2.63e-06	7.41e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CD44—stomach cancer	2.62e-06	7.38e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.6e-06	7.33e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SREBF2—stomach cancer	2.59e-06	7.3e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.58e-06	7.26e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—RORA—stomach cancer	2.56e-06	7.21e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPP2R1A—stomach cancer	2.55e-06	7.2e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TYMS—stomach cancer	2.54e-06	7.16e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTT1—stomach cancer	2.51e-06	7.08e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—NOS3—stomach cancer	2.51e-06	7.08e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTM1—stomach cancer	2.51e-06	7.08e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTP1—stomach cancer	2.5e-06	7.06e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2A6—stomach cancer	2.48e-06	7e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HMOX1—stomach cancer	2.47e-06	6.96e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CD44—stomach cancer	2.47e-06	6.95e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CD44—stomach cancer	2.44e-06	6.89e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKR1C3—stomach cancer	2.42e-06	6.81e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDOB—stomach cancer	2.4e-06	6.76e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ALB—stomach cancer	2.39e-06	6.74e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.37e-06	6.68e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ERCC2—stomach cancer	2.36e-06	6.65e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ENO1—stomach cancer	2.35e-06	6.64e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TYMS—stomach cancer	2.33e-06	6.56e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.32e-06	6.53e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTM1—stomach cancer	2.3e-06	6.49e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—stomach cancer	2.3e-06	6.48e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NOS3—stomach cancer	2.29e-06	6.44e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPP2R1A—stomach cancer	2.28e-06	6.42e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTP1—stomach cancer	2.24e-06	6.3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALOX5—stomach cancer	2.23e-06	6.28e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPP2R1A—stomach cancer	2.22e-06	6.27e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MTHFR—stomach cancer	2.22e-06	6.25e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—stomach cancer	2.22e-06	6.25e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HMOX1—stomach cancer	2.2e-06	6.22e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—DPYD—stomach cancer	2.19e-06	6.18e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTP1—stomach cancer	2.18e-06	6.15e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ERCC2—stomach cancer	2.16e-06	6.1e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HMOX1—stomach cancer	2.15e-06	6.07e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPP2R1A—stomach cancer	2.1e-06	5.91e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—stomach cancer	2.09e-06	5.89e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CD44—stomach cancer	2.09e-06	5.89e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TYMS—stomach cancer	2.08e-06	5.86e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPP2R1A—stomach cancer	2.08e-06	5.86e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTP1—stomach cancer	2.06e-06	5.8e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTM1—stomach cancer	2.05e-06	5.79e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CAV1—stomach cancer	2.05e-06	5.77e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APOA1—stomach cancer	2.04e-06	5.76e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTP1—stomach cancer	2.04e-06	5.75e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MTHFR—stomach cancer	2.03e-06	5.73e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TYMS—stomach cancer	2.03e-06	5.72e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HMOX1—stomach cancer	2.03e-06	5.72e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.03e-06	5.71e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HMOX1—stomach cancer	2.01e-06	5.67e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTM1—stomach cancer	2.01e-06	5.65e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.96e-06	5.51e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTT1—stomach cancer	1.94e-06	5.47e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ERCC2—stomach cancer	1.93e-06	5.45e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—stomach cancer	1.92e-06	5.41e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.92e-06	5.4e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMS—stomach cancer	1.91e-06	5.39e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMS—stomach cancer	1.9e-06	5.34e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTM1—stomach cancer	1.89e-06	5.33e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ERCC2—stomach cancer	1.89e-06	5.31e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CAV1—stomach cancer	1.88e-06	5.29e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTM1—stomach cancer	1.87e-06	5.28e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APOA1—stomach cancer	1.87e-06	5.28e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—stomach cancer	1.87e-06	5.26e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.86e-06	5.26e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ENO1—stomach cancer	1.82e-06	5.12e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MTHFR—stomach cancer	1.82e-06	5.12e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—stomach cancer	1.8e-06	5.07e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.79e-06	5.05e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ERCC2—stomach cancer	1.78e-06	5.01e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.78e-06	5.01e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MTHFR—stomach cancer	1.77e-06	5e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ERCC2—stomach cancer	1.76e-06	4.96e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTP1—stomach cancer	1.74e-06	4.91e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HMOX1—stomach cancer	1.72e-06	4.84e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CAV1—stomach cancer	1.67e-06	4.72e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APOA1—stomach cancer	1.67e-06	4.71e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MTHFR—stomach cancer	1.67e-06	4.71e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MTHFR—stomach cancer	1.66e-06	4.67e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—stomach cancer	1.65e-06	4.65e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CAV1—stomach cancer	1.63e-06	4.61e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APOA1—stomach cancer	1.63e-06	4.6e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMS—stomach cancer	1.62e-06	4.57e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALB—stomach cancer	1.62e-06	4.56e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CD44—stomach cancer	1.61e-06	4.54e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTM1—stomach cancer	1.6e-06	4.51e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.6e-06	4.51e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NOS3—stomach cancer	1.55e-06	4.36e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CAV1—stomach cancer	1.54e-06	4.34e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOA1—stomach cancer	1.54e-06	4.33e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CAV1—stomach cancer	1.53e-06	4.3e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOA1—stomach cancer	1.52e-06	4.29e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ERCC2—stomach cancer	1.51e-06	4.24e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALB—stomach cancer	1.48e-06	4.18e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—stomach cancer	1.47e-06	4.15e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.46e-06	4.11e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—stomach cancer	1.44e-06	4.05e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NOS3—stomach cancer	1.42e-06	4e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—stomach cancer	1.42e-06	3.99e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MTHFR—stomach cancer	1.41e-06	3.99e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—stomach cancer	1.41e-06	3.99e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.37e-06	3.86e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—stomach cancer	1.35e-06	3.82e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTP1—stomach cancer	1.34e-06	3.79e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—stomach cancer	1.34e-06	3.78e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HMOX1—stomach cancer	1.33e-06	3.74e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALB—stomach cancer	1.32e-06	3.73e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CAV1—stomach cancer	1.3e-06	3.68e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOA1—stomach cancer	1.3e-06	3.67e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—stomach cancer	1.3e-06	3.66e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALB—stomach cancer	1.29e-06	3.64e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—stomach cancer	1.29e-06	3.63e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NOS3—stomach cancer	1.27e-06	3.57e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMS—stomach cancer	1.25e-06	3.52e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.25e-06	3.51e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NOS3—stomach cancer	1.24e-06	3.48e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTM1—stomach cancer	1.24e-06	3.48e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALB—stomach cancer	1.22e-06	3.43e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALB—stomach cancer	1.21e-06	3.4e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NOS3—stomach cancer	1.16e-06	3.28e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ERCC2—stomach cancer	1.16e-06	3.27e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—stomach cancer	1.16e-06	3.26e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NOS3—stomach cancer	1.15e-06	3.25e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—stomach cancer	1.15e-06	3.23e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—stomach cancer	1.13e-06	3.19e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MTHFR—stomach cancer	1.09e-06	3.08e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—stomach cancer	1.07e-06	3e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—stomach cancer	1.06e-06	2.98e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALB—stomach cancer	1.03e-06	2.91e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CAV1—stomach cancer	1.01e-06	2.84e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOA1—stomach cancer	1e-06	2.83e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NOS3—stomach cancer	9.87e-07	2.78e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—stomach cancer	9.02e-07	2.54e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—stomach cancer	8.85e-07	2.5e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—stomach cancer	8.71e-07	2.45e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—stomach cancer	7.98e-07	2.25e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALB—stomach cancer	7.96e-07	2.24e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NOS3—stomach cancer	7.62e-07	2.15e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—stomach cancer	7.13e-07	2.01e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—stomach cancer	6.96e-07	1.96e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—stomach cancer	6.95e-07	1.96e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—stomach cancer	6.55e-07	1.85e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—stomach cancer	6.5e-07	1.83e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—stomach cancer	5.55e-07	1.57e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—stomach cancer	4.28e-07	1.21e-05	CbGpPWpGaD
